Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Joshua

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Blood|July 1, 1993
Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: evidence from the Ig heavy chain geneQ M Ralph, M J Brisco, D E Joshua, et al.
Blood|January 12, 2001
Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survivalP J Ho, R D Brown, G J Pelka, et al.
Australian and New Zealand Journal of Medicine|April 1, 1986
Complications associated with indwelling venous Hickman catheters in patients with hematological disordersM P Harvey, R J Trent, D E Joshua, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetronA S Coates, A Childs, K Cox, et al.
Nature|December 21, 1989
Mechanism of antigen-driven selection in germinal centresY J Liu, D E Joshua, G T Williams, et al.
Lancet (London, England)|February 22, 1975
Androgen-induced hepatomaG C Farrell, D E Joshua, R F Uren, et al.
International Journal of Laboratory Hematology|January 3, 2013
Performance evaluation of the Abbott CELL-DYN Emerald for use as a bench-top analyzer in a research settingT-L Khoo, N Xiros, F Guan, et al.
Hematologic Pathology|January 1, 1989
Multiple myeloma: evidence that light chains play an immunoregulatory role in B-cell regulationR A Ioannidis, D E Joshua, P T Warburton, et al.
British Journal of Haematology|April 1, 1997
Australian Leukaemia Study Group myeloma II: a randomized trial of intensive combination chemotherapy with or without interferon in patients with myelomaD E Joshua, R Penny, J P Matthews, et al.
European Journal of Haematology|April 1, 1996
Nucleoside transporters, bcl-2 and apoptosis in CLL cells exposed to nucleoside analogues in vitroA J Petersen, R D Brown, J Gibson, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Blood|July 1, 1993
Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: evidence from the Ig heavy chain geneQ M Ralph, M J Brisco, D E Joshua, et al.
Blood|January 12, 2001
Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survivalP J Ho, R D Brown, G J Pelka, et al.
Australian and New Zealand Journal of Medicine|April 1, 1986
Complications associated with indwelling venous Hickman catheters in patients with hematological disordersM P Harvey, R J Trent, D E Joshua, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetronA S Coates, A Childs, K Cox, et al.
Nature|December 21, 1989
Mechanism of antigen-driven selection in germinal centresY J Liu, D E Joshua, G T Williams, et al.
Lancet (London, England)|February 22, 1975
Androgen-induced hepatomaG C Farrell, D E Joshua, R F Uren, et al.
International Journal of Laboratory Hematology|January 3, 2013
Performance evaluation of the Abbott CELL-DYN Emerald for use as a bench-top analyzer in a research settingT-L Khoo, N Xiros, F Guan, et al.
Hematologic Pathology|January 1, 1989
Multiple myeloma: evidence that light chains play an immunoregulatory role in B-cell regulationR A Ioannidis, D E Joshua, P T Warburton, et al.
British Journal of Haematology|April 1, 1997
Australian Leukaemia Study Group myeloma II: a randomized trial of intensive combination chemotherapy with or without interferon in patients with myelomaD E Joshua, R Penny, J P Matthews, et al.
European Journal of Haematology|April 1, 1996
Nucleoside transporters, bcl-2 and apoptosis in CLL cells exposed to nucleoside analogues in vitroA J Petersen, R D Brown, J Gibson, et al.
Pageof 9